Low Dose Intravenous Ketamine in Treatment Resistant Depression Patients
Status:
Completed
Trial end date:
2017-08-16
Target enrollment:
Participant gender:
Summary
The primary goal of the project is to study the effect of Ketamine on cortical
neurophysiological function in TRD patients. The proposal employs robust and non-invasive
neurophysiological techniques TMS and EEG to investigate the cortical excitability and
oscillatory activity in patients with treatment resistant depression.
Phase:
Phase 2
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston